Cargando…
COVID-19 and low-dose radiation therapy
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of the coronavirus disease 2019 (COVID-19), has caused more than 179 million infections and 3.8 million deaths worldwide. Global health authorities working on the COVID-19 outbreak continue to explore methods to red...
Autores principales: | Dunlap, Neal E., van Berkel, Victor, Cai, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429076/ https://www.ncbi.nlm.nih.gov/pubmed/34522905 http://dx.doi.org/10.1016/j.radmp.2021.09.004 |
Ejemplares similares
-
Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence?
por: Rödel, Franz, et al.
Publicado: (2020) -
Effectiveness of low-dose radiation therapy to improve mortality of COVID-19
por: Ghaznavi, Hamid
Publicado: (2021) -
Caution warranted for low-dose radiation therapy for Covid-19
por: Das, Indra J, et al.
Publicado: (2021) -
Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls
por: Venkatesulu, Bhanu P, et al.
Publicado: (2020) -
Low dose radiation therapy for COVID-19: Effective dose and estimation of cancer risk
por: García-Hernández, Trinitat, et al.
Publicado: (2020)